MARINA DJURASEVIC: Open Payments
NPI 1649760224 · TROY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,018 in 89 payments from 17 companies in 2025. Trend: 2023 $1,494 · 2024 $2,565 · 2025 $2,018
Food & beverage: $2,018
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $530 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $310 |
| GENZYME CORPORATION | 7 | $272 |
| QOL Medical, LLC | 4 | $173 |
| Intercept Pharmaceuticals, Inc. | 4 | $119 |
| Lilly USA, LLC | 5 | $110 |
| Ardelyx, Inc. | 3 | $75 |
| Daiichi Sankyo Inc. | 3 | $64 |
| Janssen Biotech, Inc. | 3 | $63 |
| Organon LLC | 3 | $58 |
Products named: RINVOQ, DUPIXENT, Sucraid, ENTYVIO, OCALIVA, OMVOH, EOHILIA, LINZESS.
Industry payments across MI — which companies pay providers there.
